Quinapril Hydrochloride Tablet Shortage: Latest FDA Availability and Manufacturer Updates

What’s in Shortage

Quinapril Hydrochloride (Brand Name: QUINAPRIL) in tablet form is currently listed on the FDA drug shortage database. This medication is categorized under cardiovascular treatments. The shortage was first posted on January 19, 2023, and the status was last updated on February 2, 2026.

Which Manufacturers Are Affected

The following manufacturer is currently reporting availability for Quinapril Hydrochloride tablets:

Chartwell Molecular Holdings LLC

• Status: Available
• Presentations:
  • 5 mg (NDC 62135-484-60)
  • 10 mg (NDC 62135-485-90)
  • 20 mg (NDC 62135-486-90)
  • 40 mg (NDC 62135-487-90)
• Contact Info: 845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com

Why There’s a Shortage

The FDA source data does not provide a specific reason for the current shortage status of Quinapril Hydrochloride.

What Patients Should Do

If you are currently prescribed Quinapril Hydrochloride, consider the following steps:

• Consult your pharmacist: Check if your specific dosage is in stock or if they can source it from the available manufacturer.
• Contact your healthcare provider: Discuss your treatment plan and ask about potential alternatives if you encounter difficulty filling your prescription.
• Contact the manufacturer: You may reach out to Chartwell Molecular Holdings LLC directly using the contact information provided above for updates on supply.

Disclaimer: Patients should always consult their healthcare provider or a qualified medical professional before making any changes to their medication or treatment plan.

Source

Information provided by the FDA Drug Shortage Database.